Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sodium oxybate ER by Avadel Pharmaceuticals for Idiopathic Hypersomnia (IH): Likelihood of Approval
Sodium oxybate ER is under clinical development by Avadel Pharmaceuticals and currently in Phase III for Idiopathic Hypersomnia (IH). According...
Sodium oxybate ER by Avadel Pharmaceuticals for Type 2 Narcolepsy (Narcolepsy without Cataplexy): Likelihood of Approval
Sodium oxybate ER is under clinical development by Avadel Pharmaceuticals and currently in Phase III for Type 2 Narcolepsy (Narcolepsy...
Sodium oxybate ER by Avadel Pharmaceuticals for Type 1 Narcolepsy (Narcolepsy with Cataplexy): Likelihood of Approval
Sodium oxybate ER is under clinical development by Avadel Pharmaceuticals and currently in Phase III for Type 1 Narcolepsy (Narcolepsy...